Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02881957 · ClinicalTrials.gov registry record · Phase 2
Hypovitaminosis D in Neurocritical Patients
A Phase 2 study of Stroke and Spinal Cord Injuries, sponsored by University of Utah.
- Completed
- Registry status
- Phase 2
- Development phase
- 274
- Enrollment target
- 1
- Study location
NCT02881957 is a Phase 2 study of Stroke and Spinal Cord Injuries that has completed, run by University of Utah. The registered enrollment target is 274 participants, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT02881957, a Phase 2 study of Stroke and Spinal Cord Injuries, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 274 participants
- Enrollment target
- 1
- Study location
Study Summary
Vitamin D has been shown to impact prognosis in a variety of retrospective and randomized clinical trials within an intensive care unit (ICU) environment. Despite these findings, there have been no studies examining the impact of hypovitaminosis D in specialized neurocritical care units (NCCU). Given the often significant differences in the management of patients in NCCU and more generalized intensive care units there is a need for further inquiries into the impact of low vitamin D levels in this specific environment. This study proposes a randomized, double-blinded, placebo-controlled, single center evaluation of vitamin D supplementation in the emergent NCCU patient population. The primary outcome will involve length-of-stay for emergent neurocritical care patients. Various secondary outcomes, including in-hospital mortality, ICU length-of-stay, Glasgow Outcome Score on discharge, complications and quality-of-life metrics. Patients will be followed for 6 months post-discharge.
Conditions Studied
Interventions
- OTHER Placebo
- DRUG Cholecalciferol
Study Locations (1)
Utah
- University of Utah Hospital - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 274 participants |
| Start Date | 2016-10-10 |
| Est. Completion | 2018-10-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02881957
The ClinicalTrials.gov registry entry for NCT02881957 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 274 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 12,016-participant average among 454 other Stroke trials with a reported enrollment target (98% lower). The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 10 conditions, with Stroke appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.
NCT02881957 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT02881957 about?
NCT02881957 is a clinical study titled "Hypovitaminosis D in Neurocritical Patients". Vitamin D has been shown to impact prognosis in a variety of retrospective and randomized clinical trials within an intensive care unit (ICU) environment. Despite these findings, there have been no studies examining the impact of hypovitaminosis D in specialized neurocritical care units (NCCU). Give...
What is the current status of trial NCT02881957?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 274 participants. The study started on 2016-10-10. Estimated completion is 2018-10-10.
What conditions does trial NCT02881957 study?
This clinical trial studies the following conditions: Stroke, Spinal Cord Injuries, Critical Illness, Vitamin D Deficiency, Seizures.
What interventions are being tested in trial NCT02881957?
The interventions under investigation include: Placebo (OTHER), Cholecalciferol (DRUG).
Who is sponsoring clinical trial NCT02881957?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02881957 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Wearable Biofeedback for Swallowing Disorders Rehabilitation in Stroke and Parkinson Disease
RECRUITING · Phase 2
-
Balancing Effortful and Errorless Learning in Naming Treatment for Aphasia
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation + Language Therapy to Treat Mild Aphasia
RECRUITING · Phase 2
-
Novel Wrist Sensor System to Promote Hemiparetic Arm Use in Home Daily Life of Chronic Stroke Survivors
RECRUITING · Phase 2
-
Transcranial Magnetic Stimulation + Language Therapy to Treat Subacute Aphasia
RECRUITING · Phase 2
-
Myofascial Dysfunction in Post Stroke Shoulder Pain
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.